1. Marcelis C, Doevendans PA, Bonne G: Dilated cardiomyopathy, in Doevendans PA, Wilde AA (eds): Cardiovascular Genetics for Clincians. Dordrecht, The Netherlands, Kluwer Academic Publishers, 2001, pp 155-168.
2.
2. Doevendans PA, Wilde AA: Cardiovascular Genetics for Clinicians, Dordrecht, The Netherlands, Kluwer Academic Publishers, 2001.
3.
3. Dassen WR, Spiering W, de Leeuw P, Smits P, et al: Unravelling gene interactions to find the cause of atherosclerosis, a multigenic disease, using an artificial network. CIC28:373-376, 2001.
4.
4. Hingorani AD: Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis154:521-527, 2001.
5.
5. Jachymova M, Horky K, Bultas J, et al: Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun284:426-430, 2001.
6.
6. Guzik TJ, Black E, West NE, et al: Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis. Am J Med Genet100:130-137, 2001.
8. Jongbloed RJE, Marcelis C, Velter C, et al: DHPLC analysis of potassium ion channel genes in congenital Long QT syndrome. Hum Mutat20(5):382-389, 2002.
9.
9. Sylvius N, Tesson F, Gayet C, et al: A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6ql2-ql6. Am J Hum Genet68:241-246, 2001.
10.
10. Siu BL, Niimura H, Osborne JA, et al: Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation99:1022-1026, 1999.
11.
11. Krajinovic M, Pinamonti B, Sinagra G, et al: Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am J Hum Genet57:846-852, 1995.
12.
12. Durand JB, Bachinski LL, Bieling LC, et al: Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation92:3387-3389, 1995.
13.
13. Tesson F, Sylvius N, Pilotto A, et al: Epidemiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy. Eur Heart J21:1872-1876, 2000.
14.
14. Li D, Tapscoft T, Gonzalez O, et al: Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation100:461-464, 1999.
15.
15. Goldfarb LG, Park KY, Cervenakova L, et al: Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet19:402-403, 1998.
16.
16. Tsubata S, Bowles KR, Vatta M, et al: Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest106:655-662, 2000.
17.
17. Kamisago M, Sharma SD, DePalma SR, et al: Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med343:1688-1696, 2000.
18.
18. Fatkin D, MacRae C, Sasaki T, et al: Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med341:1715-1724, 1999.
19.
19. Muchir A, Bonne G, van der Kooi AJ, et al: Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet9:1453-1459, 2000.
20.
20. Bonne G, Di Barletta MR, Varnous S, et al: Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet21:285-288, 1999.
21.
21. Schwartz ML, Cox GF, Lin AE, et al: Clinical approach to genetic cardiomyopathy in children. Circulation94:2021-2038, 1996.
22.
22. Berko BA, Swift M. X-linked dilated cardiomyopathy. N Engl J Med316:1186-1191, 1987.
23.
23. Muntoni F, Cau M, Ganau A, et al: Brief report: Deletion of the dystrophin muscle-promoter region associated with Xlinked dilated cardiomyopathy. N Engl J Med329:921-925, 1993.
24.
24. Ferlini A, Sewry C, Melis MA, et al: X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord9:339-346, 1999.
25.
25. Franz WM, Muller M, Muller OJ, et al: Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet355:1781-1785, 2000.
26.
26. Bione S, D'Adamo P, Maestrini E, et al: A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet12:385-389, 1996.
27.
27. Bione S, Maestrini E, Rivella S, et al: Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet8:323-327, 1994.
28.
28. Andersson B, Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol28:162-167, 1996.
29.
29. Veldman BA, Spiering W, Doevendans PA, et al: The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens20:2023-2027, 2002.
30.
30. Schafers RF, Nurnberger J, Rutz A, et al: Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunit. Pharmacogenetics11:461-470, 2001.
31.
31. Karvonen J, Kauma H, Kervinen K, et al: Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med251:102-110, 2002.
32.
32. Tiret L, Mallet C, Poirier O, et al: Lack of association be-tween polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: The CARDIGENE study. J Am Coll Cardiol35:29-35, 2000.
33.
33. Small KM, Wagoner LE, Levin AM, et al: Synergistic polymorphisms of betaland alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med347:1135-1142, 2002.
34.
34. Suzuki M, Carlson KM, Marchuk DA, et al: Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy. Circulation105:1824-1829, 2002.
35.
35. Yamada Y, Ichihara S, Izawa H, et al: Association of a G994 -*T (Val279 -Phe) polymorphism of the plasma plateletactivating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy. J Hum Genet46:436-441, 2001.
36.
36. Port JD, Bristow MR: Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol33:887-905, 2001.
37.
37. Winnicki M, Somers VK, Accurso V, et al: Alpha-Adducin Gly46OTrp polymorphism, left ventricular mass and plasma renin activity. J Hypertens20:1771-1777, 2002.
38.
38. Tang W, Devereux RB, Rao DC, et al: Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study. Am Heart J143:854-860, 2002.
39.
39. Hallberg P, Karlsson J, Kurland L, et al: The CYP2C9 genotype predicts the blood pressure response to irbesartan: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. J Hypertens20:2089-2093, 2002.
40.
40. Tiago AD, Badenhorst D, Skudicky D, et al: An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. Cardiovasc Res54:584-589, 2002.
41.
41. Nigro V, de Sa ME, Piluso G, et al: Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet14:195-198, 1996
42.
42. Messina DN, Speer MC, Pericak-Vance MA, et al: Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet61:909-917, 1997.
43.
43. Jung M, Poepping I, Perrot A, et al: Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2ql4-q22. Am J Hum Genet65:1068-1077, 1999.
44.
44. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest97:528-532, 1996.
45.
45. Bowles KR, Gajarski R, Porter P, et al: Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest98:1355-1360, 1996.
46.
46. Schonberger J, Levy H, Grunig E, et al: Dilated cardiomyopathy and sensorineural hearing loss: A heritable syndrome that maps to 6q23-24. Circulation101:1812-1818, 2000.
47.
47. Vigouroux C, Magre J, Vantyghem MC, et al: Lamin A/C gene: Sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes49:1958-1962, 2000.
48.
48. Lim LE, Duclos F, Broux O, et al: Beta-sarcoglycan: Characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet11:257-265, 1995.
